Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestMortgage LoansNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - DoubtfulReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Total Current Liabilities (2023 - 2025)

WORK Medical Technology (WOK) posted Total Current Liabilities of $12.0 million for Q3 2025, down 36.92% on a QoQ basis from $19.0 million in Q1 2025, and down 40.68% year-over-year from $20.2 million in Q3 2024.

WORK Medical Technology (WOK) has 3 years of Total Current Liabilities data on file, last reported at $12.0 million in Q3 2025.

  • In Q3 2025, Total Current Liabilities fell 40.68% year-over-year to $12.0 million; the TTM figure through Sep 2025 stood at $12.0 million (down 40.68% YoY), while the FY2025 annual figure was $12.0 million, down 40.68% from the prior year.
  • Total Current Liabilities slipped to $12.0 million in Q3 2025, from $19.0 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $20.2 million in Q3 2024 and bottomed at $12.0 million in Q3 2025.
  • A 3-year average of $17.5 million and a median of $19.0 million in 2023 frame the typical range for Total Current Liabilities.
  • Annual changes were most pronounced in 2024 — Total Current Liabilities gained 6.64% — and 2025, when it slumped 40.68%.
  • Year by year, Total Current Liabilities stood at $18.9 million in 2023, then increased by 6.64% to $20.2 million in 2024, then slumped by 40.68% to $12.0 million in 2025.
  • The last three Total Current Liabilities figures came in at $12.0 million (Q3 2025), $19.0 million (Q1 2025), and $20.2 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 18.38 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 6.32 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.50 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 4.57 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 1.41 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 8.70 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 2.22 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 8.53 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.15 Bn
10 WORK Medical Technology - - - 11.97 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 11.97 Mn
Mar 31, 2025 18.98 Mn
Sep 30, 2024 20.18 Mn
Sep 30, 2023 18.92 Mn